PITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today ...
Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) is one of 1,051 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare ...